8-K 1 eightk.txt NORICOM NAME CHANGE TO A J&J PHARMA U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) or the Securities Exchange Act of 1934 Date of Report: June 5, 2002 NORICOM INC. (Exact Name Of Registrant As Specified In Its Charter) Commission File No. 000-32767 Nevada 86-1024812 (State or other Jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number.) 7373 N Scottsdale Road, Suite D215, Scottsdale, AZ 85253. 480-941-4902 (Address, including zip code, including area code, and telephone number of registrant's principal executive offices) None (Former name and former address, if changed since last report) ITEM 5. OTHER EVENTS Amendments to the Company's Articles of Incorporation The Shareholders of the Company have approved an amendment to its Articles of Incorporation. The amendment is to Article I , and is made for the purpose of changing the name of the Corporation from Noricom, Inc. to A J&J Pharma, Corporation. The name change became effective on June 3, 2002. On June , June 5, 2002 the Corporation filed with the Secretary of State of the State of Nevada a Certificate of Amendment to its Articles of Incorporation, evidencing such name change. The date of adoption of the above amendment to Articles I by the Shareholders of this Corporation, is June 3, 2002. Change of company address In connection with the above amendment and events having taken place, the Company has changed its address to PO Box 13087, Scotttsdale, Arizona 85267. ITEM 7. FINANCIALS STATEMENTS AND EXHIBITS Financial Statements: None Exhibit 1 - Articles of Amendment SIGNATURES In accordance with Section 12 of the Securities Exchange Act of 1934, the registrant caused this registration statement to be signed on its behalf by the undersigned, who are duly authorized. Registrant: Noricom, Inc. Date: June 5, 2002 /s/ Kevin Ericksteen ------------------------------- Keven Ericksteen President and Director